Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Castrate-resistant Prostate Cancer × dactolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroendocrine Tumors 1 Neoplasms 1 Malignant Solid Tumour 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Glioblastoma 1 Castrate-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

dactolisib 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01717898 2018-03-27

A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

University of California, San Francisco

Phase 1/2 Terminated

6 enrolled 5 charts

Castrate-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡